Recent updates in **Becton, Dickinson and Company (BDX)** have reflected an active **investment scene**. Multiple entities such as **Asset Management One Co. Ltd**, **Marks Group Wealth Management Inc.** and **Savant Capital LLC** have increased their holdings. Simultaneously, others like **Vontobel Holding Ltd.** and **Fiera Capital Corp** have reduced their stakes. Becton Dickinson reported strong **revenue growth** in their **Quarter 1 2025** earnings call. They're also looking to **divest** its life sciences unit at a **$30 billion** valuation for more corporate focus. The company's board announced a noteworthy **increase in dividends** for the 53rd consecutive year and also approved a **share repurchase** program. The company's **Q1 2025 earnings** exceeded Wall Street's projections with an EPS beating estimates by $0.43. However, they lowered their outlook after weathering a **4.7% loss** for investors over the last five years. There's also been active insider trading, including director buying of **1,500 shares**. Becton Dickinson's switch to be more nimble in the healthcare sphere has elicited a positive response with multiple price target raises and financial advisories strengthening their positions. The company recently separated its **biosciences** and **diagnostic solutions** business while also resolving its SEC investigation.
Becton Dickinson and BDX News Analytics from Thu, 02 May 2024 07:00:00 GMT to Sat, 15 Feb 2025 11:02:14 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -2
